Literature DB >> 6757980

Histamine antagonists and asthma.

N M Eiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6757980     DOI： 10.1016/0163-7258(82)90015-8

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  5 in total

Review 1.  Exercise-induced bronchospasm in the elite athlete.

Authors:  Kenneth W Rundell; David M Jenkinson
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

2.  Respiratory symptoms related to work in a factory manufacturing cimetidine tablets.

Authors:  I L Coutts; S Lozewicz; M B Dally; A J Newman-Taylor; P S Burge; A C Flind; D J Rogers
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-12

3.  Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist.

Authors:  J H Fleisch; L E Rinkema; K D Haisch; C A Whitesitt
Journal:  Agents Actions       Date:  1987-02

4.  Discovery and preliminary pharmacology of Sch 37370, a dual antagonist of PAF and histamine.

Authors:  M M Billah; R W Egan; A K Ganguly; M J Green; W Kreutner; J J Piwinski; M I Siegel; F J Villani; J K Wong
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

5.  Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs.

Authors:  M Uchida; N Imanishi; T Sugasawa; S Morooka
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.